TSN
50
-2
GILD
47
-8
GM
74
5
MDLZ
32
-4
LRCX
37
-9
KR
36
-6
AMAT
33
-13
PEG
62
4
VNO
46
-13
EMR
71
-3
F
56
-3
MAS
52
-4
BSX
64
-3
AAPL
40
-6
CFG
74
2
BXP
49
-3
TRIP
50
-4
PPG
57
-3
BDX
56
10
DHR
32
-6
TSN
50
-2
GILD
47
-8
GM
74
5
MDLZ
32
-4
LRCX
37
-9
KR
36
-6
AMAT
33
-13
PEG
62
4
VNO
46
-13
EMR
71
-3
F
56
-3
MAS
52
-4
BSX
64
-3
AAPL
40
-6
CFG
74
2
BXP
49
-3
TRIP
50
-4
PPG
57
-3
BDX
56
10
DHR
32
-6
Financhill
Back

BNY Mellon Responsible Hrzns Corp Bd ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
34

RHCB
BNY Mellon Responsible Hrzns Corp Bd ETF

Last Price:
46.46
Seasonality Move:
4.23%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
34
BNY Mellon Responsible Hrzns Corp Bd ETF (RHCB) is a Sell

Is BNY Mellon Responsible Hrzns Corp Bd ETF a Buy, Sell or Hold?

  • The current BNY Mellon Responsible Hrzns Corp Bd ETF [RHCB] share price is $46.46. The Score for RHCB is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • RHCB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RHCB Stock Price Chart

What is BNY Mellon Responsible Hrzns Corp Bd ETF's stock price today?

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RHCB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 47.35 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 46.74) Buy
Bollinger Bands (100): (46.03 - 47.31) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RHCB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.38 Buy
20-day SMA: 46.35 Buy
50-day SMA: 46.95 Sell
200-day SMA: 46.06 Buy
8-day EMA: 46.41 Buy
20-day EMA: 46.46 Sell
50-day EMA: 46.65 Sell
200-day EMA: 46.2 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

BNY Mellon Responsible Hrzns Corp Bd ETF Earnings Growth & RHCB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

BNY Mellon Responsible Hrzns Corp Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):